Generated by Meeveem AI
"Global specialty pharmaceuticals for rare diseases and emergency medicine"
SERB Pharmaceuticals supplies essential medicines for rare diseases and medical emergencies to healthcare providers in over 100 countries. The company maintains the world's broadest antidote portfolio, including medical countermeasures for chemical, biological, radiological and nuclear risks. Healthcare systems, first responders and emergency agencies rely on SERB when every moment counts. The company operates as a fully integrated platform managing acquisition, development, manufacturing and commercialisation. With over 70 medicines and operations in the US, Europe and Middle East, SERB delivers specialist treatments for urgent, life threatening conditions through expertise in complex niche products.
530
Team Members
1951
Founded
Pharma
Sector
Hybrid
Work Environment
A world where every healthcare provider can access critical medicines instantly, ensuring no patient with a rare disease or facing a medical emergency goes without the treatment they need to survive and recover.
At SERB Pharmaceuticals, our mission is to be a dedicated ally to healthcare providers treating patients with critical conditions.